"the drug must be administered at the right time point during development," he said.
.
.: "targeted cgrp small molecule antagonists for acute migraine therapy."
.
the latest figures mean that since january 2000, scottish widows has paid a total of £2.5bn in claims to more than 86,000 customers.
.
.
.
.